<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6456646\results\search\tropicalVirus\results.xml">
  <result pre="papillomavirus (HPV) which resulted in histological regression and/or eliminated persistent" exact="HPV" post="infection and HPV-related cervical lesions (Kim et al., 2014;"/>
  <result pre="vaccine was developed that induced protective neutralizing antibodies (NAb) to" exact="Zika" post="virus (ZIKV) in mice (Larocca et al., 2016) and"/>
  <result pre="al., 2017) leading to the development of safe and immunogenic" exact="ZIKV" post="DNA vaccines for humans (Tebas et al., 2017; Gaudinski"/>
  <result pre="loaded nanoparticles (NP), adenovirus (Ad) vectors, adeno-associated virus (AAV), and" exact="HPV" post="pseudovirus (HPV PsV) have been developed to elicit localized"/>
  <result pre="(Holz et al., 2018). In the vagina, intravaginal delivery of" exact="HPV" post="PsV, and more recently Ad26 and Ad35 have been"/>
  <result pre="D.et al.. (2017). Durability and correlates of vaccine protection against" exact="Zika" post="virus in rhesus monkeys. Sci. Transl. Med.9:eaao4163. 10.1126/scitranslmed.aao416329237759 AckermanM."/>
  <result pre="S.BuckC. B.KinesR. C.PangY. Y.DayP. M.et al.. (2012). Intravaginal immunization with" exact="HPV" post="vectors induces tissue-resident CD8+ T cell responses. J. Clin."/>
  <result pre="M.HuZ.YamshchikovG.RothwellR. S.et al.. (2018). Safety, tolerability, and immunogenicity of two" exact="Zika" post="virus DNA vaccine candidates in healthy adults: randomised, open-label,"/>
  <result pre="T.HurS. Y.YangH. G.SeoY. B.HongS. R.et al.. (2014). Clearance of persistent" exact="HPV" post="infection and cervical lesion by therapeutic DNA vaccine in"/>
  <result pre="LaroccaR. A.AbbinkP.PeronJ. P.ZanottoP. M.IampietroM. J.Badamchi-ZadehA.et al.. (2016). Vaccine protection against" exact="Zika" post="virus from Brazil. Nature536, 474â€“478. 10.1038/nature1895227355570 LatimerB.ToporovskiR.YanJ.PankhongP.MorrowM. P.KhanA. S.et"/>
  <result pre="age of direct-acting antivirals?PLoS ONE11:e0156213. 10.1371/journal.pone.015621327224423 SunY.PengS.QiuJ.MiaoJ.YangB.JeangJ.et al.. (2015). Intravaginal" exact="HPV" post="DNA vaccination with electroporation induces local CD8+ T-cell immune"/>
 </snippets>
</snippetsTree>
